U.K. To Deny Most Imports From Third Wockhardt Production Plant
This article was originally published in PharmAsia News
Executive Summary
A third Wockhardt production plant in India has been blacklist by the U.K.'s drug-regulatory body for failing to meet good manufacturing practices.